IN2014CH01012A - - Google Patents

Info

Publication number
IN2014CH01012A
IN2014CH01012A IN1012CH2014A IN2014CH01012A IN 2014CH01012 A IN2014CH01012 A IN 2014CH01012A IN 1012CH2014 A IN1012CH2014 A IN 1012CH2014A IN 2014CH01012 A IN2014CH01012 A IN 2014CH01012A
Authority
IN
India
Prior art keywords
silica particles
treatment
saliva
urine
bind
Prior art date
Application number
Other languages
English (en)
Inventor
Kanth Vangala Rajani
Oyyaram Madhavan
GV Madankumar
Original Assignee
Thrombosis Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thrombosis Res Inst filed Critical Thrombosis Res Inst
Priority to IN1012CH2014 priority Critical patent/IN2014CH01012A/en
Publication of IN2014CH01012A publication Critical patent/IN2014CH01012A/en

Links

Landscapes

  • Silicon Compounds (AREA)
IN1012CH2014 2014-02-28 2014-02-28 IN2014CH01012A (enrdf_load_stackoverflow)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1012CH2014 IN2014CH01012A (enrdf_load_stackoverflow) 2014-02-28 2014-02-28

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1012CH2014 IN2014CH01012A (enrdf_load_stackoverflow) 2014-02-28 2014-02-28

Publications (1)

Publication Number Publication Date
IN2014CH01012A true IN2014CH01012A (enrdf_load_stackoverflow) 2015-09-04

Family

ID=54395163

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1012CH2014 IN2014CH01012A (enrdf_load_stackoverflow) 2014-02-28 2014-02-28

Country Status (1)

Country Link
IN (1) IN2014CH01012A (enrdf_load_stackoverflow)

Similar Documents

Publication Publication Date Title
MX2017015758A (es) Componente de dispositivo, dispositivo, y metodo para purificar y ensayar biomoleculas de muestras biologicas.
MX2019002946A (es) Anticuerpos anti-pd-1 y sus usos.
MX368177B (es) Proceso continuo de múltiples etapas para purificar anticuerpos.
PH12016501366A1 (en) Novel anti-baff antibodies
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
MA40390A (fr) Procédés d'analyse impliquant des nanoparticules dissociables
SG10201903822XA (en) Method for the enrichment of circulating tumor dna
WO2015195453A3 (en) Methods for increasing the capacity of flow-through processes
EP3201350A4 (en) Method for nucleic acid analysis directly from an unpurified biological sample
GEP20227382B (en) Anti-coagulation factor xi antibodies
MX2013010019A (es) Metodo para aislamiento de osteopontina utilizando alimentos concentrados.
MX2015005874A (es) Anticuerpos especificos del factor de crecimiento b derivados de plaquetas y composiciones y usos de estos.
PH12021550521A1 (en) Antibodies that potently neutralize rabies virus and other lyssaviruses and uses thereof
PH12019502298A1 (en) Monoclonal antibody to pd-l1
MY192018A (en) Antibody capable of neutralizing substance having activity alternative to function of coagulation factor viii (fviii)
MX2017007381A (es) Miembros de union para homologo del oncogen de fibrosarcoma musculoadoneurotico (c-maf) humano.
SG10201807572PA (en) Robust antibody purification
EA201792538A1 (ru) Способ биологического получения метакриловой кислоты
TW201613981A (en) Compositions and methods for the diagnosis of rheumatoid arthritis
EA201892231A1 (ru) Способ очистки белка
WO2016075546A3 (en) Antibodies that neutralize ebola virus and uses thereof
MY179359A (en) Methods for purification of a virus produced in vitro and clearance assay for the virus
HK1254804A1 (zh) 将核细胞从未经核化的红细胞分离的方法
GB2541596A (en) Method and composition for determining specific antibody responses to species of filovirus
IN2014CH01012A (enrdf_load_stackoverflow)